AlphAIAlphAI — Financial news for AI agents
mcknightshomecare.comSEP 163 min read$INNV

InnovAge finishes fiscal 2026 strong, but rate challenges may lie ahead

InnovAge reported Q4 2026 revenue of $262M (up 18.3% YoY) and net income of $9.78M, reversing a $5M loss from Q4 2025. Full-year revenue rose 15.9% to $989M, with a net loss of $683K, improved from $35.3M in 2025. CEO Patrick Blair highlighted operational improvements and growth investments, while CFO Benjamin Adams noted potential rate challenges in 2027.

Original reporting
mcknightshomecare.com
Published Sep 16, 2026, 4:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 5:49 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
InnovAge finishes fiscal 2026 strong, but rate challenges may lie ahead — source image
Source · mcknightshomecare.com
Decision brief

The 30-second read

$INNVBullishMed
01

Why it matters

Earnings beat and narrowed losses suggest operational improvements, but rate pressure remains a key risk.

02

Market read

Strong Q4 results may prompt short‑term buying, while guidance on a tougher 2027 rate environment adds caution.

03

What to watch

Potential impact of new leadership and M&A exploration may drive longer‑term growth.

Relevance 7/10Novelty 7/10Timing: post-quarter earnings release

Background

InnovAge is the only publicly traded PACE provider, serving dual‑eligible seniors across six states.

Company-level read

Ticker impact

$INNVBullishHigh confidence
Context

InnovAge reported Q4 revenue of $262M and a net income of $9.78M, plus full-year revenue of $989M and a narrowed net loss, indicating strong earnings performance.

Expected impact

Potential modest price rise on earnings beat, pending market reaction to rate outlook.

Evidence & confidence

Revenue growth and a swing to profit in Q4 are material; however, guidance on a tougher rate environment tempers upside.

Market effects

Sector

Highlights pressure on PACE providers from Medicare/Medicaid rate uncertainty.

Regional

California and Colorado rate negotiations could affect other senior‑care operators in those states.

Global

Limited to U.S. value‑care segment.

Counterpoint

What could challenge this read

If rate cuts materialize, the stock could underperform despite earnings beat.

Key entities

  • Executive
    Patrick Blair

    CEO of InnovAge, discussed earnings and rate outlook.

  • Executive
    Jennifer Browne

    New President and COO, former Optum executive.

Read at source← All news

Related articles

SEP 16
$INNVMed

InnovAge Holding Corp. Signals Breakout Year in Earnings

InnovAge Holding Corp. (INNV) reported strong Q4 and fiscal 2026 results, with adjusted EBITDA up 175% YoY to $94.6M. Revenue rose 15.9% to $989.7M, and net income improved significantly. Management expects continued growth in fiscal 2027, with revenue guidance of $1.05B to $1.085B and adjusted EBITDA of $105M to $115M. The company highlighted operational improvements, cost reductions, and strategic investments.

tipranks.com3 min
SEP 10
$INNVMedAI 8/10

InnovAge Holding Corp. Q4 2026 Earnings Call Summary

InnovAge Holding Corp. completed 'InnovAge 2.0' in 2026, focusing on operational improvements. 'InnovAge 3.0' will prioritize scaling and expansion. For 2027, the company projects 1.5% to 2.0% net Medicare rate increases and revenue of $1.05B to $1.085B, with growth driven by enrollment and utilization management. Management prefers M&A over de novo centers for capital allocation.

yahoo.com3 min
SEP 9
$INNVHighAI 8/10

InnovAge (INNV) Q4 2026 Earnings Call Transcript

InnovAge (INNV) reported Q4 2026 revenue of $262.0M, up 18.3% YoY, and net income of $9.8M. Full-year revenue rose 15.9% to $989.7M, with adjusted EBITDA increasing 174.2% to $94.6M. The company guided FY 2027 revenue to $1.05B-$1.085B and adjusted EBITDA to $105M-$115M, citing census growth and rate increases. Management highlighted expansion plans and potential M&A activity, while noting risks from Medicaid rate uncertainties in key states.

fool.com3 min
SEP 9
$INNVHighAI 9/10

InnovAge shares jump 13% as fiscal 2027 guidance tops $1bn

InnovAge Holding Corp (INNV) reported fiscal 2026 results and fiscal 2027 guidance of $1.05bn to $1.085bn in revenue. Shares rose 13.12% to $11.90. Management reported a 175% increase in adjusted EBITDA, though GAAP net income showed volatility. The company plans to scale operations and expand value-based care. Three private-equity sponsors filed SEC forms around the earnings release.

financial-news.co.uk2 min